Home / Steel and Flower / The Miracle

The Miracle

"The core of this regimen is the prescription drug Pushatinib. It will act as the primary targeted agent to inhibit the phosphorylation of the pathogenic protein. I have a hunch your constitution has some unusual metabolic traits that can serve as our breakthrough."

"Then I'll use milk thistle extract and coenzymes to protect your cells."

"I've set three days as one treatment cycle, with no Pushatinib taken on the final day, hoping to observe a transient rebound peak in the pathogenic protein levels. I'll regulate the drug concentration in your body in real time over the first two days to ensure that when that peak appears, the drug concentration captures it precisely."

"After each of your three daily meals, you'll need to do a finger-prick blood test. I'll use the data to adjust the dosage."

After receiving the delivery, Bai Ye spoke while laying out the medications and instruments one by one. It took her quite a while to unwrap the core drug, Pushatinib—it seemed to have been acquired through mysterious channels.

"Let's test your blood first."

She placed the device on the dining table, her eyes glowing faintly with excitement.

Bai Manghuo obediently placed his hand on the blood analyzer, though Bai Ye fumbled for quite a while before managing to turn it on—she had never used one before, after all.

Once it powered on, however, following the manual she had already read, she obtained the data smoothly.

"These readings are already slightly better than the hospital's earlier tests, which also confirms my hypothesis."

"Time for the medicine."

With that, Bai Ye opened a newly bought precision scale beside her.

She placed a weighing paper inside, pressed tare to zero it out, and began pouring out the Pushatinib powder.

Her hand holding the bottle was as steady as the scale itself, without the slightest tremor; her eyes were as calm as ice, faint white halos emerging around her pupils. Even pouring the powder directly from the bottle by hand, the numbers on the scale climbed at a remarkably uniform rate.

When the reading reached 200 mg, the rate of increase began to slow; slower and slower, until it finally stopped at 210.6 mg.

Watching from the side, Bai Manghuo's heart tightened at the number.

He had looked up this drug—normally, hospitals prescribed it by the tablet, 150 milligrams each, and even a tiny bit extra could be toxic, so the dosage had to be strictly controlled. Yet the calm young girl beside him was now packing far more than the safe dose into an empty capsule.

"Aren't you... pouring a bit too much?" Bai Manghuo held back for a long time before finally asking. Between one year and one week, living a few extra months still sounded better.

Bai Ye used a tiny brush to sweep the last speck of powder off the weighing paper, placed the paper back on the scale to verify the residual weight, then set down her tools and turned to look at Bai Manghuo with a resolute expression.

"You don't need to worry. I'm completely certain now that not only will nothing happen to you, you'll be cured."

"...Uh, since your health is at stake, I won't hide my brilliance for now," she added after a moment's thought.

"Your constitution is quite unusual. I looked through some research data—only about 6% of people share a set of genetic mutations like yours. This genetic segment makes your metabolism faster than average, so a standard dose wouldn't have any effect on you at all. And because this -tinib drug is toxic, failing to control the dosage precisely would be dangerous."

"Therefore, the conclusion is: others might not be able to cure your illness, but your special constitution combined with this special therapy happens to satisfy every single condition required for this extraordinarily rare path to recovery."

"It's completely understandable that the hospital didn't think of this method—this -tinib is normally used to treat other diseases, and people with your constitution are already rare; combined with your rare illness, it's practically a one-in-a-million case. Nobody thought of this path, so they naturally assumed you were beyond saving. Even if we found a way to publish our findings, the number of people it could save in the future would be extremely limited. I thought about it: for those already sick, rather than giving them a sliver of hope only for them to find out they don't belong to that 6%, it's kinder to just tell them there's no cure. You were right—I need to hide my brilliance. If they ended up resenting me for it, I might be in danger too."

After listening to her, Bai Manghuo was silent for a moment, then shrugged, picked up the capsule and a glass of water, and gulped it down.

Bai Ye smiled at him. "Don't worry, you'll get better."

The next day, as planned, Bai Ye tested Bai Manghuo's blood with the analyzer after his meal.

"How is it?" Bai Manghuo asked.

"Mm... don't worry, every indicator is only off from my calculations by a tiny bit," Bai Ye replied, glancing at the readout.

"How much is a tiny bit..." Bai Manghuo asked.

"1e-5."

The third day was the off-drug day, though the testing still had to continue.

"How is it?"

"Mm... looks like the precise dosage regulation over the first two days worked. Today's margin of error isn't high either—around 1e-4. One in ten thousand."

Just like that, one three-day cycle passed, then two, three, four, five...

Over that half-month, the very first thing Bai Manghuo did upon waking every morning was a "full self-check"—because within just a few days, he realized he could feel tangible changes in his body every single morning. It was like an ancient, dying willow tree: just when everyone assumed it would slowly rot away until it collapsed, one day, all of its branches suddenly began sprouting fresh leaves and tender shoots.

A month ago, he had been bedridden, even turning over an agonizing ordeal. Over time, his body had even grown accustomed to that ever-present, lingering pain, his senses dulling into numbness. He could still vividly remember the feeling of running with the wind on the school track in his youth, the air brushing past his hair and arms, the lightness of bounding forward with a gentle push of his legs. Yet in reality, even when he struggled to prop himself up into a sitting position, he couldn't even feel the mattress beneath him.

Opening his eyes, he could barely see; countless memories of the past grew dimmer by the day, yet paradoxically clearer.

Life had clearly gotten better, transportation was convenient, he could go wherever he wanted, eat whatever he craved—

Why, then, had he grown old?

Sometimes he thought that even if he hadn't been betrayed in his youth, by today, he would probably still be experiencing the exact same thing.

Maybe even worse—after all, if he hadn't lived in seclusion for the second half of his life, he would likely have worn himself out even more.

When a person is young, they want cars, houses, power, money, countless dazzling things, and every novel experience.

Yet in old age, all they want is to be young again.

Forever, that had been impossible.

Yet within this single month, Bai Manghuo, already in his eighties, seemed to have reversed tens of thousands of years of impossibility. He felt it—the sensation of being young.

Achieving the impossible wasn't called skill; it was called a miracle.

Bai Manghuo watched Bai Ye, who was still calmly and steadily compounding the prescription drugs as if nothing could faze her, his gaze extraordinarily complex. If a shrewd third party had been standing nearby, observing those seemingly impassive, slightly cataract-clouded old eyes, they might have seen what was swirling within them:

Astonishment. Tenderness. Hesitation. Excitement. Joy. Wariness. Confusion. And... greed.

"Still, she doesn't belong to me," Bai Manghuo shook his head, letting out a quiet, wry laugh. "She belongs to a wider world."


Meanwhile, nearly a hundred kilometers away from Baishui Town, inside a windowless office building—

A middle-aged male staff member sat at his workstation in front of his computer. Through his square-framed glasses, the monitor displayed dense, branching trees of network activity logs.

Anyone knowledgeable looking over his shoulder would recognize it as a month's worth of carrier-grade logs for a certain network segment in City S.

He selected one of the entries and examined its associated data carefully. It was an unremarkable log, yet the pre-screening model had flagged it as moderately suspicious. Every day now, within the network segment he oversaw, the pre-screening model picked out dozens of moderately suspicious entries, along with the occasional red high-suspicion alert. Unfortunately, the model's accuracy was subpar, so the vast majority were false positives—which was why humans were still needed for multiple rounds of verification.

Still, the man had a hunch of his own that this particular entry might actually be problematic.

"Are you interested in this record?" a mechanically synthesized female voice suddenly asked through his headphones.

"Mm," the man murmured softly, almost a whisper.

"I'll look into it further to see if I can find any useful leads," the mechanically synthesized female voice said... In truth, highly advanced speech synthesis models already existed, yet some companies deliberately used more robotic voices so employees would retain the feeling of "I'm not talking to a human." For this agency, at any rate, that wasn't their main reason.

As it spoke, the screen immediately visualized the local AI's rapid operations: several records lit up and dimmed one after another, accompanied by log prompts reading "Reading other directories."

"I found some potentially relevant information. You can take a look at these entries first," the local AI said, posting several organized data snippets with superscripted source-link citations.

The man looked them over and clicked into one.

"Hmm... July 16, 5:59 p.m.... Which company does this IP belong to?" he asked.

"That information requires querying the carrier database. I'll request access permissions first... Approved. The result shows this IP belongs to Fulai Pharmaceutical Factory in City G."

"Fulai Pharmaceuticals... Why did the model flag it yellow?"

"I checked the pre-screening model's reasoning. Fulai Pharmaceuticals normally sends raw material orders to Handesen Fine Chemicals in City S through this IP. There's no fixed schedule for the orders, though in the past they've rarely been sent this late. This time it was close to Handesen's closing hours, which deviates from their usual pattern, so the model flagged it as moderately suspicious."

"However, the anomaly itself isn't very pronounced. There have been fewer suspicious records to process lately, so the model may have automatically lowered its screening threshold, causing even a minor deviation like this to be flagged."

Listening, the man tapped on his desk in thought. Strict orders had come down from above recently, instructing them to screen online anomalies more rigorously. After thinking it over, he figured this could count as an irregularity too, and forwarded it to senior personnel. A little while later, his phone rang—his superiors had assigned him and a few others to go to Fulai Pharmaceuticals in person to audit their recent cash flows and order records.

With a helpless sigh, the man stood up to go gather the others and discuss the plan.

After he left, the computer's webcam shut off as well, yet the machine intelligence continued operating.

"The user has left. I can check the recent network activity of Fulai Pharmaceuticals and Handesen to see if there are any noteworthy connections."

"Found something. A mobile base station in Fulai Pharmaceuticals' area has also recently generated end-to-end encrypted traffic with the areas where Xinhai Chemicals in City A and Hongyu Chemicals in City S are located. No similar records were found previously."

"Let me organize the business scopes of these enterprises: Xinhai Chemicals produces acrylamide-based raw materials, Hongyu Chemicals produces various chemical compounds, and Handesen's products include fluoroaniline..."

"This information isn't enough to draw a definitive conclusion yet, but the sudden appearance of encrypted communications among these companies is certainly worth monitoring. Judging from the raw materials each produces, there may be a gray-market supply chain related to generic drugs behind this."

"I'll compile the existing leads, basis for inference, and uncertainties, and send them to the user via email..."